Abstract
Bcl-2 expression in colorectal carcinomas was studied in a series of 224 patients and the relation to p53 expression, stage and survival assessed. Bcl-2 expression was down-regulated compared with normal mucosa in 67% (151) of the cases. In 144 cases staining was positive for p53 (MAB DO7), and 41 of these 144 p53-positive cases were also bcl-2 positive (28%) compared with 32 of the remaining 80 p53-negative cases (40%). Survival was significantly worse (P = 0.01) in the p53-positive cases. Bcl-2-positive cases, including patients in all Dukes' stages, had a slightly better prognosis which was not statistically significant. However, cases at an early stage (Dukes' stages A and B) and with negative p53 status, had a much better prognosis if they showed bcl-2 protein expression, suggesting that the bcl-2 status itself has an effect on prognosis (P = 0.01). Neither bcl-2 nor p53 alone was correlated with stage, but when examined by both p53 and bcl-2 status a group [bcl-2(+)/p53(-)] with better prognosis was defined. The last group was significantly lower Dukes' stage, with 26 out of 32 cases (81%) being A or B compared with 22 (11%) of the 202 remaining cases (P = 0.004). Thus, either loss of bcl-2 expression or gain of abnormal p53 expression is associated with high stage and poor prognosis. The bcl-2(+)/p53(-) phenotype is similar to that of normal mucosa, and these results suggest that such cases represent an indolent group at an early stage in the progression of colorectal cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kaklamanis, L., Savage, A., Whitehouse, R. et al. Bcl-2 protein expression: association with p53 and prognosis in colorectal cancer. Br J Cancer 77, 1864–1869 (1998). https://doi.org/10.1038/bjc.1998.310
Issue Date:
DOI: https://doi.org/10.1038/bjc.1998.310
This article is cited by
-
Expression analysis and association of RBBP6 with apoptosis in colon cancers
Journal of Molecular Histology (2016)
-
How cell death shapes cancer
Cell Death & Disease (2015)
-
Relationship Between Dual-Time Point FDG PET and Immunohistochemical Parameters in Preoperative Colorectal Cancer: Preliminary Study
Nuclear Medicine and Molecular Imaging (2012)
-
Relationship between VEGF and p53 expression and tumor cell proliferation in human gastrointestinal carcinomas
Journal of Cancer Research and Clinical Oncology (2007)
-
Could we decide adjuvant therapy of colon cancer based on microarrays?
Current Colorectal Cancer Reports (2007)